9-phenanthrol has been researched along with arsenic trioxide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ban, T; Huo, R; Li, J; Liang, XQ; Tang, HX; Wu, XY; Xue, YD; Xue, ZM; Yu, CX; Zhang, YY; Zhu, H | 1 |
1 other study(ies) available for 9-phenanthrol and arsenic trioxide
| Article | Year |
|---|---|
Transient receptor potential melastatin 4 contributes to early-stage endothelial injury induced by arsenic trioxide.
Topics: Antineoplastic Agents; Arsenic Trioxide; Cell Survival; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Phenanthrenes; RNA Interference; RNA, Messenger; TRPM Cation Channels; Up-Regulation | 2019 |